BIPROGY Inc.

As of March 31, 2026, BIPROGY Inc. carries a market capitalization of 446.18B, placing it among publicly traded companies globally. Its enterprise value stands at 475.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

BIPROGY Inc.'s next confirmed earnings release is scheduled for November 5, 2026.

As of March 31, 2026, BIPROGY Inc. has 96.58M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, BIPROGY Inc. maintains a current ratio of 1.11, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, BIPROGY Inc.'s stock has declined approximately 15.15% over the past 52 weeks. The 50-day moving average sits at 4,722.80, while the 200-day moving average is 4,728.09.

As of March 31, 2026, BIPROGY Inc. holds 48.39B in cash and equivalents against 75.65B in total debt, resulting in a net debt position of 3.68B. Total book value stands at 178.99B, with working capital of 17.02B providing operational flexibility.